PT  - JOURNAL ARTICLE
AU  - Gountas, Ilias
AU  - Quattrocchi, Annalisa
AU  - Mamais, Ioannis
AU  - Tsioutis, Constantinos
AU  - Christaki, Eirini
AU  - Fokianos, Konstantinos
AU  - Nikolopoulos, Georgios
TI  - Effect of public health interventions during the first epidemic wave of COVID-19 in Cyprus: a modelling study
AID  - 10.1101/2021.01.02.20248980
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.01.02.20248980
4099  - http://medrxiv.org/content/early/2021/01/04/2021.01.02.20248980.short
4100  - http://medrxiv.org/content/early/2021/01/04/2021.01.02.20248980.full
AB  - Background Cyprus addressed the first wave of SARS CoV-2 (COVID-19) by implementing non-pharmaceutical interventions. The aims of this study were: a) to estimate epidemiological parameters of this wave including infection attack ratio, infection fatality ratio, and case ascertainment ratio, b) to assess the impact of public health interventions, and c) to examine what would have happened if those interventions had not been implemented.Methods A dynamic, stochastic, individual-based Susceptible-Exposed-Infected-Recovered (SEIR) model was developed to simulate COVID-19 transmission and progression in the population of the Republic of Cyprus. The model was fitted to the observed trends in COVID-19 deaths and intensive care unit (ICU) bed use.Results By May 8 2020th, the infection attack ratio was 0.31% (95% Credible Interval (CrI): 0.15%, 0.54%), the infection fatality ratio was 0.71% (95% CrI: 0.44%, 1.61%), and the case ascertainment ratio was 33.2% (95% CrI: 19.7%, 68.7%). If Cyprus had not implemented any public health measure, the healthcare system would have been overwhelmed by April 14th. The interventions averted 715 (95% CrI: 339, 1235) deaths. If Cyprus had only increased ICU beds, without any social distancing measure, the healthcare system would have been overwhelmed by April 19th.Conclusions The decision of the Cypriot authorities to launch early non-pharmaceutical interventions limited the burden of the first wave of COVID-19. The findings of these analyses could help address the next waves of COVID-19 in Cyprus and other similar settings.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Onisilos funding scheme of the University of Cyprus.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:It is a modeling study. No ethical approvement is requiredAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data are in the manuscript